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Abstract 
Aim: There is a lack of studies on frailty prevalence and the association between frailty and 
mortality in a Norwegian general population. Findings regarding sex differences in the 
association between frailty and mortality have been inconsistent. The aim of this study was to 
investigate the association between the frailty phenotype and all-cause mortality in men and 
women in a Norwegian cohort study. 
Methods: We followed 712 participants (52% women) aged 70 years and older participating 
in the population-based Tromsø 5 Study in 2001-02 for all-cause mortality up to 2016. The 
frailty status at baseline was defined by a modified version of Fried’s frailty criteria. Cox 
regression models were used to analyze the association between frailty and mortality with 
adjustment for age, sex, disability, comorbidity, smoking status and years of education.  
Results: In total, 3.8% (n=27) of participants were frail (women: 4.4%, men: 3.2%) and 38.1% 
(n=271) were pre-frail (women: 45.8%, men: 29.9%). During follow-up (mean 10.1 years), 501 
(70%) participants died. We found an increased risk of mortality for frail elderly (multivariate-
adjusted HR 4.16 (95% CI 2.40, 7.22)) compared to non-frail elderly. In sex-stratified analysis 
the adjusted HR was 7.09 (95% CI 3.03, 16.58) for frail men and 2.93 (95% CI 1.38, 6.22) for 
frail women. Results for pre-frailty showed an overall weaker association with mortality. 
Conclusions: While frailty was more prevalent in women than in men, the findings suggest 
that the association between frailty and mortality is stronger in men than in women.  
 
Keywords: Cohort Studies, Epidemiology, Frail Elderly, Mortality, Norway  
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Introduction 
A challenging manifestation of the aging population is the clinical condition of frailty1. 
Although there is no universal definition, frailty is, with growing consensus, considered a 
“syndrome of decreased reserve and resistance to stressors”2 following an age-related 
accumulative degeneration of several physiologic systems and leading to a state of increased 
risk of adverse health outcomes like falls, disability, institutionalization and mortality1-4. For 
frail individuals this implies that stressors like changes in medication use or minor illnesses can 
lead to a drastic decline in health1. The exact pathophysiology of frailty is still uncertain but is 
thought to be a multifactorial interaction of physiology, lifestyle, environment, genes and 
disease5. Even though there is no gold standard for an operational definition, one of the most 
frequently used approaches is the frailty phenotype suggested by Fried and colleagues in 2001, 
which defines frailty as the presence of three or more of the following characteristics: 
unintentional weight loss, low grip strength, exhaustion, low walking speed and low physical 
activity2. The association between the presence of frailty and an increased risk of mortality has 
been described before2, 6-8, but there is a lack of studies on frailty prevalence and the association 
between frailty and mortality in a Norwegian general population. Further, previous studies 
showed inconsistent results regarding sex differences in this association8-11. The aim of this 
study is to investigate the association between the frailty phenotype and all-cause mortality 
among community-dwelling men and women aged 70 years and older in a Norwegian 
population-based study.  
 
Methods 
Sample 
The Tromsø Study is a population-based study in the Tromsø municipality consisting of 
seven surveys conducted between 1974 and 2016 (Tromsø 1-7), to which total birth cohorts and 
random samples of the population were invited (participation rates 65-79%). A total of 40,051 
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women and men participated in one or more surveys. Data collection consisted of 
questionnaires, biological sampling and clinical examinations. In Tromsø 4-7 a predefined 
group was invited to a second, more extensive clinical examination after attending the first 
visit12, 13.  
Participants in the second examination of Tromsø 4 and additional samples in the age 
groups 30, 40, 45, 60 and 75 were eligible for invitation to Tromsø 5 (2001-02). A total of 
10,353 women and men were invited and 8130 (79%) attended12. Questionnaires for 
participants 70 years and older included all covariates of interest for the present analysis. 
Therefore, our sample included participants from Tromsø 5 aged 70 years or older (n=2,131, 
participation rate 83%). We excluded subjects with incomplete data for frailty definition 
(n=1419), leaving 712 participants (52% women) aged 70-87 years for analysis (Figure 1). 
Norway has a unique personal identification system that allows exact matching of 
population register data. The Tromsø Study participant list was linked to the Norwegian Cause 
of Death Registry and the participants were followed until 1st of January 2016, death or 
emigration, whichever came first. None of the included participants emigrated from Norway 
during follow-up, i.e. mortality follow-up was complete.  
The Regional Committee of Medical and Health Research Ethics and the Norwegian 
Data Protection Authority have approved the Tromsø Study, and all procedures were performed 
in accordance with the 1964 Helsinki declaration and its later amendments. The participants 
gave written informed consent. 
 
Frailty Measurement  
A modified version of the frailty phenotype by Fried et al.2 was used to identify frailty 
based on exhaustion, grip strength, walking speed and physical activity level. Information about 
unintentional weight loss was unavailable. All single frailty markers were dichotomized. 
Participants with score 0 on all frailty markers were considered non-frail, those with 1 or 2 as 
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pre-frail and those with 3 or more present frailty markers were considered frail.  
Exhaustion was defined through one item from the Hopkins Symptom Checklist 10 
(HSCL-10): “During the last week, have you experienced that everything is a struggle?”. 
Participants reporting one of the highest two (“pretty much” or “very much”) of four categories 
were considered exhausted. Physical activity level was defined by self-reported weekly average 
of light (not sweating/out of breath) and hard (sweating/out of breath) leisure time physical 
activity, where 0 weekly hours in light and hard physical activity were considered low physical 
activity. Walking speed was assessed by the Timed Up and Go (TUG) test (time for the 
participant to rise from a chair, walk three meters, turn around, walk back to the chair and sit 
down14, 15). The participants were instructed to perform the test with footwear and could use the 
chair’s armrests as support, if needed. The cut-off for low walking speed was set to 15 seconds, 
which is the middle ground of various suggested cut-points16, 17 and has previously been shown 
to be the preferred threshold for prediction of falls15. Grip strength was measured using a Martin 
vigorimeter (bar). The participants were given two attempts and were instructed not to support 
their arm against anything and to use their non-dominant hand. The results were divided into 5 
centiles adjusted for sex and BMI-group (≤24, 24.1-26, 26.1-28 and >28). The lowest centile 
(the weakest 20%) was considered low grip strength in accordance with the suggestion from 
Fried and colleagues2 and has previously been shown to have high agreement with population-
independent cut points for the Fried criteria18. A comparison of the frailty definition in the 
present study and the original Fried criteria is presented in the supporting information (Table 
S1). 
 
Covariates 
Age was included as a continuous variable. Self-reported smoking status was 
dichotomized into current daily smoking or non-smoking at baseline. Years of education were 
grouped into primary school (7 years), high school (8-12 years) and college/university (13+ 
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years). Comorbidity was defined through self-report (previous and/or current disease) of two 
or more of the following diseases at baseline: pulmonary disease (asthma/chronic 
bronchitis/emphysema), cancer, diabetes, stroke, coronary heart disease (angina pectoris and/or 
heart attack) and peptic ulcer, based on the Charlson Comorbidity Index (CCI)19 without 
weighting of diseases. Disability was defined as difficulties in performing everyday activities 
due to chronic health problems (mobility inside own home, moving out of home without 
assistance, participation in leisure-time activities, using public transport or performing 
necessary daily errands). Participants reporting some or great difficulties in one or more daily 
activities were classified as disabled.  
 
Statistics 
Baseline characteristics are presented as frequencies and mean values stratified by 
frailty status (Table 1), sex (Table S2) and completeness of frailty data (Table S3). Statistical 
differences were tested with χ2-tests and t-test or linear regression for categorical and 
continuous variables, respectively. Frequencies of single frailty markers stratified by sex at 
baseline are presented in Table 2. Cox regression was used to calculate hazard ratios (HR) with 
95% confidence intervals (CI) for analysis of the association between frailty status at baseline 
and all-cause mortality (Table 3, Figure 2). In accordance with Fried et al.2, the time from study 
entry up until the day of death or end of study - whichever came first - was used as the time-
scale. The log−log plot and Schoenfeld residuals were examined for the total sample and for 
men and women separately. No violation of the proportional hazards assumption was detected. 
Three regression models were run for women and men combined and separately. The first 
model included the whole sample, the second a reduced sample with complete data for all 
covariates and both models adjusted for age (and sex when women and men combined). The 
third model additionally adjusted for disability, comorbidity, smoking and education. As a 
sensitivity analysis, the third model was run again in a sample with multiply imputed missing 
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data among the covariates (Table S4). Possible interaction between sex and frailty status was 
investigated by adding interaction terms in the regression analysis. All analyses were performed 
using STATA 14.2 (StataCorp LLP, College Station, TX). A p-value of <0.05 was regarded as 
statistically significant. 
 
Results 
Mean age was 77.4 (SD ± 2.4, range = 70-87 years) with a majority of participants being 
74-81 years old (n=686). In total, 3.8% (n=27) were defined as frail and 38.1% (n=271) as pre-
frail. Among women, 4.4% were frail and 45.8% were pre-frail. Among men, 3.2% were frail 
and 29.9% were pre-frail. Frail participants differed from pre-frail and non-frail participants 
(Table 1); with increasing frailty status participants were more likely to be older, female and to 
have shorter length of education. There was a stepwise increase in comorbidity and disability 
with increasing frailty status. Among the frail individuals, 91.7% reported disability (92.3% of 
women, 90.9% of men) and 61.9% reported comorbidity (64.3% of women, 57.1% of men). 
Table 2 displays the prevalence of each frailty marker.  
Out of the 712 participants, 501 (70.4%) died during follow-up (226 women (61.6%) 
and 275 men (79.7%)). Women had a median survival of 12.5 years, whereas half of the men 
had died after 9.7 years. Among the frail, the median survival time was 5.9 and 2.8 years for 
women and men, respectively. Figure 2 displays the age-adjusted survival curves based on the 
Cox model for women and men according to their frailty status at baseline. 
Adjusted for age and sex (model 2), frail participants had a 5.96 times higher risk of death 
(CI 3.58, 9.93) compared to non-frail elderly (Table 3). After further adjustment for disability, 
comorbidity, smoking and education the hazard ratio dropped to 4.16 (CI 2.40, 7.22). When the 
analysis was stratified by sex, frail women had a 4.53 higher risk of death compared to those 
who were not frail (CI 2.34, 8.78) in the age-adjusted model. After further covariate adjustment, 
the risk of death was attenuated, but remained statistically significant (HR 2.93 (CI 1.38, 6.22)). 
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For frail men, the risk of death was 8.55 times higher compared to those who were not frail 
when adjusted for age (CI 3.84, 19.03) and 7.09 times higher in the multivariate-adjusted model 
(CI 3.03, 16.58). Pre-frailty was also associated with all-cause mortality (HR 1.50 (CI 1.18, 
1.91) relative to non-frailty after multivariate-adjustment. In sex-stratified analysis, pre-frailty 
was significantly associated with mortality in men, but not in women. In the multivariate-
adjusted model, there was a significant interaction (p = 0.046) between sex and frailty. Using 
multiple imputation attenuated the results slightly, but the conclusions remained unaltered 
(Table S4).  
 
Discussion 
In this prospective cohort study of 712 community-dwelling women and men aged 70 years 
and older we found that frailty was significantly associated with increased all-cause mortality. 
This association was stronger in men than in women.  
 
Frailty prevalence 
In accordance with our findings, several previous studies showed higher frailty 
prevalence among women compared to men2, 6, 7, 20, an increase in frailty with increasing age2, 
6, 9, 20, 21 as well as the general tendency of a higher prevalence of diseases and adverse 
socioeconomic and lifestyle-related factors among the frail2, 20, 21. 
 
Frailty, comorbidity and disability 
The overlap of frailty with comorbidity in the present study (62%) is similar to that in 
the study by Fried and colleagues (68%)2. In the present study, a vast majority of those who 
were classified as frail also reported disability (92%). In Fried et al., only 27% of the frail 
participants also reported difficulty in activities of daily living (ADL)2. However, the findings 
in the present study are in accordance with studies challenging the assumption that disability 
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and frailty only overlap modestly. Theou et al. examined the overlap of the frailty phenotype 
with disability in the Canadian Study of Health and Aging and found that 84% of frail people 
also reported disability22. In an analysis from the National Health and Nutrition Examination 
Survey (NHANES) as many as 98% of frail people aged 50 years or older had ADL disability, 
suggesting that frailty might not be a pre-disability state23. These studies all vary in the way in 
which the criteria for the frailty phenotype were modified and how disability was measured, 
which can strongly influence the amount of overlap between the concepts. Nevertheless, the 
overlap in the present study also suggest that the frailty phenotype does not only identify 
participants at high risk of disability, but more specifically those being in an especially 
vulnerable state of disability.  
 
Frailty and all-cause mortality 
We found a strong association between frailty status and all-cause mortality. Further, 
the effect sizes and interaction analysis suggest that the association is stronger for men. This is 
in accordance with results from a systematic review using the frailty phenotype, which found a 
2.66 times increased mortality risk for frail men (95% CI 2.02, 3.50) and 1.88 for frail women 
(95% CI 1.64, 2.15) compared to non-frail individuals10. Equally, a study of Mexican 
Americans aged ≥ 65 found a 3.04 times higher mortality risk for frail men (95% CI 2.16, 4.28) 
and 1.92 higher risk for frail women (95% CI 1.39, 2.65) compared to those who were non-
frail11. Theou et al. found an association between frailty and mortality that was statistically 
significant for both genders, but stronger for men on seven different frailty scales24. Conversely, 
two US studies using different frailty measures7, 9 and a Finnish study using the phenotype 
found a stronger association of frailty and mortality among women8. 
The finding of a higher frailty prevalence in women, but higher frailty-associated 
mortality in men is in line with the Male-Female Health-Survival Paradox, which refers to the 
phenomenon that women have a higher rate of disability, diseases and worse self-reported 
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health, but also greater longevity compared to men25. Women seem to be able to live longer 
with frailty, whereas men tend to die more suddenly7, 8. Women are also more likely to have a 
stronger social support system and to actively seek help when needed compared to men10, 11, 
which could compensate for some of the risk associated with frailty.  
 
Limitations 
Volunteer bias and missingness of frailty measures affect the estimation of the true 
prevalence of the frailty phenotype and its association with mortality. Study participants tend 
to be healthier than non-attendees26. Non-attendance by the most ill individuals may have led 
to an underestimation of frailty prevalence and its association with mortality in this study.  
Participants excluded due to missing data on frailty criteria were younger and comprised 
more women and current smokers compared to those with complete frailty data, but there were 
no significant differences in disease prevalence (Table S3). 
Estimates of frailty prevalence are tentative as the identification of frailty is substantially 
influenced by varying definitions and modifications27, 28. In this analysis we used four of the 
five Fried criteria to detect frailty. If unintentional weight loss had been available for 
assessment, there might have been more individuals classified as frail or pre-frail, as suggested 
in a systematic review on modifications of the frailty phenotype where 4-item phenotype scales 
estimated lower prevalence than 5-item phenotypes28. 
The two self-reported frailty markers, exhaustion and physical activity level, might have 
been affected by information bias. A previous analysis from the Tromsø Study found that self-
reported leisure time activity is over-reported in both men and women, but the degree of 
overestimation is greater among men29. A qualitative study from Spain on gender differences 
in the perception of health and vulnerability found that women tend to emphasize their 
exhaustion and report worse self-perceived health than men, while men tend to downplay their 
health problems30. Consequently, if men did report exhaustion and inactivity in this study, it 
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might have signaled a higher severity than in women, meaning that the same frailty score for 
men and women would have been be more lethal for men. 
Most covariates were dichotomized in this analysis, which leads to loss of information 
and potential for unaccounted confounding. Comorbidity was assessed through self-report of 
current as well as previous diseases and did not include weighing for the severity of the disease. 
Furthermore, confounding of the association between frailty and mortality by the effect of 
single diseases is possible and might have led to an overestimation of the strength of 
association, given the higher disease prevalence among the frail.  
The HRs for frail participants in the present study are considerably larger than in most 
previous findings. These results have to be interpreted with caution due to the low number of 
frail people in the sample, which led to low precision of the effect estimates. 
The vast majority of participants were aged 74 to 81 years, so the findings are most valid 
for this age group. Further, the results should not be generalized to the population of older 
people living in nursing homes and the like, where the prevalence and severity of frailty is 
expected to be considerably higher than among community-dwelling individuals2, 27. 
Major strengths of the study are the high participation rate and the ascertainment of 
mortality status for every participant, resulting in complete follow-up. 
 
In this population-based study of 712 community-dwelling Norwegian women and men 
aged 70 years and older we found a significant association between frailty and mortality. 
Although frailty was more prevalent in women, the results suggest that the risk of death might 
be higher for frail men than for frail women. Continued efforts should be made to agree on 
universal definitions and measurements of frailty, in order to enable comparable research and 
to provide a firm basis for potential prevention and intervention strategies. 
 
 
 12
Disclosure statement 
The authors declare no conflict of interest. 
 
References 
1. Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. 
Lancet 2013; 381: 752-762. 
2. Fried LP, Tangen CM, Walston J et al. Frailty in older adults: evidence for a 
phenotype. J Gerontol A Biol Sci Med Sci 2001; 56: 146-156. 
3. Campbell AJ, Buchner DM. Unstable disability and the fluctuations of frailty. Age 
Ageing 1997; 26: 315-318. 
4. Rodriguez-Manas L, Feart C, Mann G et al. Searching for an operational definition of 
frailty: a Delphi method based consensus statement: the frailty operative definition-
consensus conference project. J Gerontol A Biol Sci Med Sci 2013; 68: 62-67. 
5. Morley JE. Frailty. In: Sinclair AJ, Morley JE, Vellas B, eds. Pathy’s Principles and 
Practice of Geriatric Medicine. Hoboken, NJ: John Wiley & Sons, Ltd, 2012; 1387-
1393. 
6. Rockwood K, Song X, MacKnight C et al. A global clinical measure of fitness and 
frailty in elderly people. CMAJ 2005; 173: 489-495. 
7. Puts MTE, Lips P, Deeg DJH. Sex differences in the risk of frailty for mortality 
independent of disability and chronic diseases. JAGS 2005; 53: 40-47. 
8. Kulmala J, Nykanen I, Hartikainen S. Frailty as a predictor of all-cause mortality in 
older men and women. Geriatr Gerontol Int 2014; 14: 899-905. 
9. Bartley MM, Geda YE, Christianson TJ, Pankratz VS, Roberts RO, Petersen RC. 
Frailty and Mortality Outcomes in Cognitively Normal Older People: Sex Differences 
in a Population-Based Study. J Am Geriatr Soc 2016; 64: 132-137. 
 13
10. Chang SF, Lin PL. Frail phenotype and mortality prediction: a systematic review and 
meta-analysis of prospective cohort studies. Int J Nurs Stud 2015; 52: 1362-1374. 
11. Berges IM, Graham JE, Ostir GV, Markides KS, Ottenbacher KJ. Sex differences in 
mortality among older frail Mexican Americans. J Womens Health 2009; 18: 1647-
1651. 
12. Jacobsen BK, Eggen AE, Mathiesen EB, Wilsgaard T, Njolstad I. Cohort profile: the 
Tromso Study. Int J Epidemiol 2012; 41: 961-967. 
13. Njolstad I, Mathiesen EB, Schirmer H, Thelle DS. The Tromso study 1974-2016: 40 
years of cardiovascular research. Scand Cardiovasc J 2016; 50: 276-281. 
14. Bischoff HA, Stahelin HB, Monsch AU et al. Identifying a cut-off point for normal 
mobility: a comparison of the timed 'up and go' test in community-dwelling and 
institutionalised elderly women. Age Ageing 2003; 32: 315-320. 
15. Whitney JC, Lord SR, Close JC. Streamlining assessment and intervention in a falls 
clinic using the Timed Up and Go Test and Physiological Profile Assessments. Age 
Ageing 2005; 34: 567-571. 
16. Norwegian Health Informatics. TUG - The Timed Up & Go 2016. 
https://nhi.no/skjema-og-kalkulatorer/skjema/geriatripleie/timed-up-and-go-tug/. 
[Accessed 01.10.17]. 
17. Donoghue OA, Savva GM, Cronin H, Kenny RA, Horgan NF. Using timed up and go 
and usual gait speed to predict incident disability in daily activities among community-
dwelling adults aged 65 and older. Arch Phys Med Rehabil 2014; 95: 1954-1961. 
18. Saum KU, Muller H, Stegmaier C, Hauer K, Raum E, Brenner H. Development and 
evaluation of a modification of the Fried frailty criteria using population-independent 
cutpoints. J Am Geriatr Soc 2012; 60: 2110-2115. 
 14
19. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying 
prognostic comorbidity in longitudinal studies: development and validation. J Chronic 
Dis 1987; 40: 373-383. 
20. Op het Veld LPM, van Rossum E, Kempen GIJM, de Vet HCW, Hajema K, 
Beurskens AJHM. Fried phenotype of frailty: cross-sectional comparison of three 
frailty stages on various health domains. BMC Geriatr. 2015; 15: 77. 
21. Avila-Funes JA, Helmer C, Amieva H et al. Frailty among community-dwelling 
elderly people in France: the three-city study. J Gerontol Series A Biol Sci Med Sci 
2008; 63: 1089-1096. 
22. Theou O, Rockwood MR, Mitnitski A, Rockwood K. Disability and co-morbidity in 
relation to frailty: how much do they overlap? Arch Gerontol Geriatr 2012; 55: e1-e8. 
23. Blodgett J, Theou O, Kirkland S, Andreou P, Rockwood K. Frailty in NHANES: 
Comparing the frailty index and phenotype. Arch Gerontol Geriatr 2015; 60: 464-470. 
24. Theou O, Brothers TD, Pena FG, Mitnitski A, Rockwood K. Identifying common 
characteristics of frailty across seven scales. J Am Geriatr Soc 2014; 62: 901-906. 
25. Alberts SC, Archie EA, Gesquiere LR, Altmann J, Vaupel JW, Christensen K. The 
Male-Female Health-Survival Paradox: A Comparative Perspective on Sex 
Differences in Aging and Mortality. In: Weinstein M, Lane MA, eds. Sociality, 
Hierarchy, Health: Comparative Biodemography, A collection of papers. Washington: 
The National Academies Press, 2014; 339-363. 
26. Langhammer A, Krokstad S, Romundstad P, Heggland J, Holmen J. The HUNT study: 
participation is associated with survival and depends on socioeconomic status, diseases 
and symptoms. BMC Med Res Methodol 2012; 12: 143. 
27. Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of 
disability, frailty, and comorbidity: implications for improved targeting and care. J 
Gerontol A Biol Sci Med Sci 2004; 59: 255-263. 
 15
28. Theou O, Cann L, Blodgett J, Wallace LM, Brothers TD, Rockwood K. Modifications 
to the frailty phenotype criteria: Systematic review of the current literature and 
investigation of 262 frailty phenotypes in the Survey of Health, Ageing, and 
Retirement in Europe. Ageing Res Rev 2015; 21: 78-94. 
29. Emaus A, Degerstrom J, Wilsgaard T et al. Does a variation in self-reported physical 
activity reflect variation in objectively measured physical activity, resting heart rate, 
and physical fitness? Results from the Tromso study. Scand J Public Health 2010; 38: 
105-118. 
30. Garcia-Calvente Mdel M, Hidalgo-Ruzzante N, Del Rio-Lozano M et al. Exhausted 
women, tough men: a qualitative study on gender differences in health, vulnerability 
and coping with illness in Spain. Sociol Health Illn 2012; 34: 911-926. 
 
  
 16
Table 1. Baseline characteristics by frailty status. The Tromsø Study 2001-02. 
 Total Non-Frail Pre-Frail Frail  
 (n = 712) (n = 414) (n = 271) (n = 27) p§ 
Age, mean ± SD 77.4 ± 2.4 77.2 ± 2.4 77.7 ± 2.3 78.3 ± 2.6 0.001 
Sex, n (%)      
Female 367 (51.5) 183 (44.2) 168 (62.0) 16 (59.3) < 0.001 
Male 345 (48.5) 231 (55.8) 103 (38.0) 11 (40.7)  
Education, n (%)      
≤ 7 years 322 (47.1) 156 (39.4) 148 (56.9) 18 (66.7) < 0.001 
8-12 years 289 (42.3) 186 (47.0) 95 (36.5) 8 (29.6)  
>12 years 72 (10.5) 54 (13.6) 17 (6.5) 1 (3.7)  
BMI, mean ± SD 26.6 ± 4.1 26.4 ± 3.7 26.9 ± 4.3 27.6 ± 6.2 0.039 
Daily Smoking, n (%)      
Current Smoker 113 (15.9) 55 (13.4) 51 (18.8) 7 (25.9) 0.056 
Non-Smoker 597 (84.1) 357 (86.7) 220 (81.2) 20 (74.1)  
Disability, n (%) 195 (31.2) 63 (17.2) 110 (46.8) 22 (91.7) < 0.001 
Comorbidity, n (%) 126 (22.7) 53 (16.4) 60 (28.6) 13 (61.9) < 0.001 
Disease, n (%)      
Pulmonary Disease † 110 (15.7) 55 (13.6) 48 (17.9) 7 (25.9) 0.106 
Cancer 85 (14.2) 55 (15.5) 28 (12.3) 2 (11.8) 0.552 
Diabetes 55 (7.8) 25 (6.1) 22 (8.2) 8 (29.6) < 0.001 
Stroke 56 (8.0) 18 (4.4) 27 (10.2) 11 (40.7) < 0.001 
CHD ‡ 177 (25.2) 80 (19.6) 84 (31.6) 13 (48.2) < 0.001 
Peptic Ulcer 75 (13.7) 38 (11.6) 34 (16.8) 3 (20.0) 0.189 
SMC, n (%) 102 (18.5) 48 (14.9) 48 (22.5) 6 (35.3) 0.016 
†Including asthma, chronic bronchitis and/or emphysema. ‡Including angina pectoris and/or 
heart attack. 
§p-value: Chi-square test for dichotomous or ordinal variables, linear regression for 
continuous variables. 
BMI, Body Mass Index; CHD, Coronary Heart Disease; SMC, Subjective Memory 
Complaint.  
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Table 2. Prevalence of the single frailty markers at baseline. The Tromsø Study 2001-02. 
 All Women Men 
 (n = 712) (n = 367) (n = 345) 
Exhaustion, n (%) 48 (6.8) 37 (10.1) 11 (3.2) 
Low physical activity, n (%) 97 (13.6) 65 (17.7) 32 (9.3) 
Low grip strength, n (%) 130 (18.3) 71 (19.4) 59 (17.1) 
Low walking speed, n (%) 141 (19.8) 90 (24.5) 51 (14.8) 
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Table 3. Hazard Ratios (95% Confidence Intervals) for all-cause mortality by frailty status at baseline. The Tromsø Study 2001-02. 
 Model 1† Model 2† Model 3† 
 All‡ Women Men Interaction§ All‡ Women  Men Interaction§ All‡ Women Men Interaction§ 
 (n=712) (n=367) (n=345)  (n=481) (n=235) (n=246)  (n=481) (n=235) (n=246)  
Non-
frail 
(ref.) 
1.0  1.0 1.0  1.0 1.0 1.0  1.0 1.0 1.0  
Pre-
frail 
1.57 
(1.30, 
1.90) 
1.35 
(1.03, 
1.78) 
1.76 
(1.36, 
2.27) 
0.200 1.65 
(1.32, 
2.08) 
1.37 
(0.97, 
1.92) 
1.88 
(1.39, 
2.54) 
0.173 1.50 
(1.18, 
1.91) 
1.15 
(0.78, 
1.70) 
1.65 
(1.21, 
2.25) 
0.158 
Frail 4.82 
(3.17, 
7.32) 
3.41 
(1.96, 
5.92) 
8.01 
(4.21, 
15.24) 
0.050 5.96 
(3.58, 
9.93) 
4.53 
(2.34, 
8.78) 
8.55 
(3.84, 
19.03) 
0.188 4.16 
(2.40, 
7.22) 
2.93 
(1.38, 
6.22) 
7.09 
(3.03, 
16.58) 
0.046 
†Model 1 = full sample, adjusted for age. Model 2 = sample with complete data for all covariates, adjusted for age. Model 3 = sample with complete 
data for all covariates, adjusted for age, comorbidity, disability, smoking and education. 
‡Additional adjustment for sex.  
§P-value for interaction term between frailty status and sex. 
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Figure 1. Flow diagram demonstrating inclusion and exclusion of participants for the analysis.  
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Figure 2. Age-adjusted survival curves based on the Cox model by frailty status; non-frail (thin line), 
pre-frail (medium line) and frail (thick line), for all (n=712), and women (n=367) and men (n=345) 
separately. The Tromsø Study 2001-02.  
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Table S1. Modification of the frailty phenotype in the Tromsø Study 2001-02. 
  
Criteria for frailty by Fried et al. 2001 
 
Criteria for frailty in the Tromsø Study 
Exhaustion 
 
 
Two questions from the Center for Epidemiologic 
Studies Depression Scale: 
(a) I felt that everything I did was an effort  
(b) I could not get going  
How often in the last week did you feel this way?  
0 = rarely or none of the time (<1 day)  
1 = some or a little of the time (1–2 days) 
2 = a moderate amount of the time (3-4 days) 
3 = most of the time 
 
Answer 2 or 3 led to categorization as frail by the 
exhaustion criterion. 
One question from the Hopkins Symptom Checklist 
(HSCL-10): 
Have you experienced any of this the last week: 
That everything is a struggle? 
1 = No complaint  
2 = Little complaint  
3 = Pretty much  
4 = Very much 
 
 
Answer 3 or 4 leads to categorization as frail by the 
exhaustion criterion. 
 
Physical Activity Minnesota Leisure Time Activity Questionnaire asking 
about walking, chores (moderately strenuous), mowing 
the lawn, raking, gardening, hiking, jogging, biking, 
exercise cycling, dancing, aerobics, bowling, golf, 
singles tennis, doubles tennis, racquetball, calisthenics, 
swimming. 
Kilocalories per week expended were calculated using 
a standardized algorithm. The lowest 20% were 
identified, resulting in the following cut-off for the 
physical activity criterion for frailty: 
 
Men: 
Those with <383 kilocalories of physical activity per 
week were considered frail by this criterion. 
Women:  
Those with <270 kilocalories per week were 
considered frail by this criterion. 
Self-report: How has your physical activity in leisure 
time been during this last year? Think of your weekly 
average for the year. Time spent going to work 
counts as leisure time.  
 
Light activity (not sweating/out of breath): 
1 = None 
2 = Less than 1 hour per week 
3 = 1-2 hours per week 
4 = 3 or more hours per week 
 
Hard physical activity (sweating/out of breath): 
1 = None 
2 = Less than 1 hour per week 
3 = 1-2 hours per week 
4 = 3 or more hours per week 
 
Answer 1 in both questions leads to categorization as 
frail by this criterion.  
Weight Loss In the last year, have you lost more than 10 pounds 
unintentionally (not due to dieting or exercise)?  
The answer yes led to categorization as frail for the 
weight loss criterion.  
 
 
 
Not available 
Grip Strength Measured by Jamar dynamometer (kg) 
Stratified by sex and BMI quartiles.  
Lowest 20% were identified, resulting in the following 
cut-off for the grip strength criterion for frailty: 
Men: 
BMI ≤ 24 and grip strength ≤ 29 kg  
BMI 24.1–26 and grip strength ≤ 30 kg 
BMI 26.1–28 and grip strength ≤ 30 kg 
BMI > 28 and grip strength ≤ 32 kg 
Women: 
BMI ≤ 23 and grip strength ≤ 17 kg  
BMI 23.1–26 and grip strength ≤ 17.3 kg 
BMI 26.1–29 and grip strength ≤ 18 kg 
BMI > 29 and grip strength ≤ 21 kg 
Measured by Martin vigorimeter (bar) 
Stratified by sex and BMI (≤24, 24.1-26, 26.1-28 or 
>28). 
 
Participants are categorized as frail if they are part of 
the lowest quintile for grip strength adjusted for sex 
and BMI. 
Walking Speed  Time to walk 15 feet stratified by sex and height  
(gender-specific cut-off at medium height):  
Lowest 20% were identified, resulting in the following 
cut-off for the walking speed criterion for frailty: 
Men 
Height ≤ 173 cm and ≥ 7 seconds 
Height > 173 cm and ≥ 6 seconds 
Women 
Height ≤ 159 cm and ≥ 7 seconds 
Height > 159 cm and ≥ 6 seconds 
 
Measured by Timed-Up-and-Go (TUG) test: 
Cut-off for TUG ≥15 seconds (not adjusted for height 
or sex) 
 
Participants are categorized as frail, if they needed 
more than 15 seconds to stand up from a chair, walk 
a distance of 3 meters, turn, return and sit down 
again. 
Frailty Score Categorization by sum of present characteristics: 
0 = not frail/robust 
1-2 = intermediate/pre-frail 
3 or more = frail 
Categorization by sum of present characteristics: 
0 = non-frail 
1-2 = pre-frail 
3 or more = frail 
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Table S2. Baseline characteristics by sex. The Tromsø Study 2001-02. 
 
†Including asthma, chronic bronchitis and/or emphysema. ‡Including angina pectoris and/or heart 
attack. 
§p-value: Chi-square test for dichotomous or ordinal variables, t-test for continuous variables. 
BMI, Body Mass Index; CHD, Coronary Heart Disease; SMC, Subjective Memory Complaint. 
  
 Women 
(n=367) 
Men 
 (n=345) 
p-value§ 
Age, mean ± SD 77.4 ± 2.3 77.3 ± 2.4 0.632 
Frailty phenotype, n (%)    
Non-frail 183 (49.9) 231 (67.0) <0.001 
Pre-frail 168 (45.8) 103 (29.9)  
Frail 16 (4.4) 11 (3.2)  
Education, n (%)    
≤ 7 years 198 (56.3) 124 (37.5) <0.001 
8-12 years 126 (35.8) 163 (49.2)  
>12 years 28 (8.0) 44 (13.3)  
BMI, mean ± SD 27.0 ± 4.4   26.3 ± 3.6 0.022 
Daily Smoking, n (%)    
Current Smoker 56 (15.3) 57 (16.6) 0.621 
Non-Smoker 311 (84.7) 286 (83.4)  
Disability, n (%) 115 (35.5) 80 (26.6) 0.016 
Comorbidity, n (%) 62 (22.6) 64 (22.9) 0.930 
Disease, n (%)    
Pulmonary Disease†  64 (17.9) 46 (13.5) 0.108 
Cancer 38 (12.9) 47 (15.4) 0.375 
Diabetes 34 (9.5) 21 (6.1) 0.097 
Stroke 24 (6.7) 32 (9.4) 0.188 
CHD‡  77 (21.5) 100 (29.1) 0.021 
Peptic Ulcer 29 (10.7) 46 (16.7) 0.041 
SMC, n (%) 46 (16.9) 56 (20.1) 0.330 
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Table S3. Baseline characteristics of participants (70+) with complete and missing data on frailty. The 
Tromsø Study 2001-02. 
 
†Including asthma, chronic bronchitis and/or emphysema. ‡Including angina pectoris and/or heart 
attack. 
§p-value: Chi-square test for dichotomous or ordinal variables, t-test for continuous variables. 
BMI, Body Mass Index; CHD, Coronary Heart Disease; SMC, Subjective Memory Complaint. 
  
 Complete  
frailty data  
(n = 712) 
Incomplete or missing 
frailty data  
 (n=1419) 
p-value§ 
Age, mean ± SD 77.42 ± 2.36 74.03 ± 3.16 < 0.001 
Sex, n (%)    
Female  367 (51.5) 820 (57.8) 0.006 
Male 345 (48.5) 599 (42.2)  
Education, n (%)    
≤ 7 years 322 (47.1) 610 (48.6) 0.587 
8-12 years 289 (42.3) 531 (42.3)  
>12 years 72 (10.5) 115 (9.2)  
BMI, mean ± SD 26.6 ± 4.1   26.6 ± 4.3 0.949 
Daily Smoking, n (%)    
Current Smoker 113 (15.9) 292 (20.9) 0.006 
Non-Smoker 597 (84.1) 1107 (79.1)  
Disability, n (%) 195 (31.2) 308 (28.0) 0.153 
Comorbidity, n (%) 126 (22.7) 198 (20.2) 0.253 
Disease, n (%)    
Pulmonary Disease† 110 (15.7) 210 (15.3) 0.797 
Cancer 85 (14.2) 148 (13.3) 0.597 
Diabetes 55 (7.8) 80 (5.8) 0.079 
Stroke 56 (8.0) 90 (6.6) 0.245 
CHD‡ 177 (25.2) 319 (23.1) 0.276 
Peptic Ulcer 75 (13.7) 135 (13.7) 0.987 
SMC, n (%) 102 (18.5) 158 (14.9) 0.061 
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Table S4. Hazard Ratios† (95% Confidence Intervals) for all-cause mortality by frailty status at 
baseline using multiple imputation‡. The Tromsø Study 2001-02. 
 All§ Women Men Interaction¶ 
 (n=712) (n=367) (n=345)  
Non-frail (ref.) 1.0 1.0 1.0  
Pre-frail 1.38 (1.13, 1.69) 1.11 (0.82, 1.51) 1.54 (1.18, 2.01) 0.210 
Frail 3.37 (2.15, 5.31) 2.16 (1.18, 3.96) 6.41 (3.20, 12.84) 0.017 
†adjusted for age, comorbidity, disability, smoking and education 
‡Assuming data was missing at random, multiple imputation was performed to address missing values 
among the covariates comorbidity, disability, smoking and education. Five hundred duplicate datasets 
were created to reduce sampling variability from the imputation simulation. Missing values were 
replaced by imputed values based on the observed information. The imputation model included all 
variables from the final regression model, including the interaction term between sex and frailty. The 
Nelson-Aalen cumulative hazard estimator was used as a predictor in the imputation models. Estimates 
from the five hundred imputed datasets were combined with Rubin’s rules to obtain HRs and 95% CIs. 
§Additional adjustment for sex.  
¶P-value for interaction term between frailty status and sex. 
 
 
